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Background: A new thromboembolic animal model showed beneficial effects of t-PA with an infarct volume
reduction of 36.8% in swiss mice. Because knock-out animal experiments for stroke frequently used C57BL76 mice
we evaluated t-PA effects in this mouse strain and measured infarct volume and vascular recanalisation in-vivo by
using high-field 9.4 T MRI and a 1H surface cryo coil.
Methods: Clot formation was triggered by microinjection of murine thrombin into the right middle cerebral artery
(MCA). Animals (n = 28) were treated with 10 mg/kg, 5 mg/kg or no tissue plasminogen activator (t-PA) 40 min after
MCA occlusion. For MR-imaging a Bruker 9.4 T animal system with a 1H surface cryo probe was used and a
T2-weighted RARE sequence, a diffusion weighted multishot EPI sequence and a 3D flow-compensated gradient
echo TOF angiography were performed.
Results: The infarct volume in animals treated with t-PA was significantly reduced (0.67 ± 1.38 mm3 for 10 mg/kg
and 10.9 ± 8.79 mm3 for 5 mg/kg vs. 19.76 ± 2.72 mm3 ; p < 0.001) compared to untreated mice. An additional group
was reperfused with t-PA inside the MRI. Already ten minutes after beginning of t-PA treatment, reperfusion flow was
re-established in the right MCA. However, signal intensity was lower than in the contralateral MCA. This reduction in
cerebral blood flow was attenuated during the first 60 minutes after reperfusion. 24 h after MCA occlusion and
reperfusion, no difference in signal intensity of the contralateral and ipsilateral MCAs was observed.
Conclusions: We confirm a t-Pa effect using this stroke model in the C57BL76 mouse strain and demonstrate a
chronological sequence MRI imaging after t-PA using a 1H surface cryo coil in a 9.4 T MRI. This setting will allow
testing of new thrombolytic strategies for stroke treatment in-vivo in C57BL76 knock-out mice.
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Approximately 75% of all stroke subtypes are caused by
embolism leading to cerebral vessel occlusion [1]. The
only approved specific treatment for acute stroke is
thrombolysis with tissue plasminogen activator (t-PA),
which restores cerebral blood flow and improves the
neurological outcome in patients with acute ischaemic
stroke. This therapy however is associated with certain
risks, such as secondary haemorrhage after stroke. New
treatment strategies are therefore required, rendering
the development of new animal models in combination* Correspondence: fatar@neuro.ma.uni-heidelberg.de
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distribution, and reproduction in any mediumwith adequate imaging strategies. Orset and colleagues
[2] demonstrated a stroke model in mice with t-PA
induced reperfusion mimicking the clinical situation. In
this model thromboembolic stroke is induced by local
injection of purified thrombin directly into the right
MCA. The resulting fibrin-rich embolus can be com-
pletely dissolved by t-PA [2].
The in vivo localisation and classification of stroke in
the murine brain model and the determination of the le-
sion size by means of magnetic resonance imaging
(MRI) is still challenging, because very small anatomical
sizes require ultra high spatial resolution. The signal-
to-noise ratio (SNR) increase of a cryogenic transmit/re-
ceive coil compared to a room temperature coil of com-
parable dimensions by a factor of 2.5 makes imaging ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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sible without the use of any exogenous contrast agents
[3,4].
The purpose of this study was to evaluate this
thromboembolic model in C57BL/6 mice and to deter-
mine the infarcted area after MCA occlusion (MCAo)
with and without subsequent reperfusion by means of
MRI. Furthermore, a common three-dimensional time of
flight (3D-TOF) angiography [5-7] was used with the
cryo coil to demonstrate time development of the t-PA
induced reperfusion.
Methods
Animals
Male C57BL/6 mice (25–30 g; Charles River, Sulzfeld,
Germany) – not swiss mice as in Orset et al [2]- were
housed under standard conditions with open access to
food and water. All experiments were approved by the
local Ethical Committee in accordance with the animal
protection guidelines and European Communities Coun-
cil guidelines.
MCA occlusion
The animals were anesthetised with 1.5-2% isofluran
(Abbott, Wiesbaden, Germany) in a mixture of oxygen/
air (1:1) administered via a face mask and placed in a
stereotactic frame. MCA occlusion was induced by
thrombin injection, as described elsewhere [2]. Briefly,
the skin between the right eye and the right ear was
incised and the temporal muscle was retracted. To ex-
pose the MCA, a small craniotomy was performed and
the dura mater was excised. A micropipette was intro-
duced into the lumen of the MCA and 2 μL (1.5 U) of
purified murine alpha-thrombin (Haematologic Tech-
nologies, Vermont, USA) were injected to induce the
formation of a clot. Ten minutes after injection the clot
had stabilised and the micropipette was removed. After
surgery the incision wound was sutured.
T-PA induced thrombolysis
In 20 animals t-PA (Actilyse, Boehringer Ingelheim,
Germany) was intravenously injected into the tail vein
40 min after MCAo to induce thrombolysis. This was
not in accordance with the described model by Orset
and colleagues [2], as the thrombin formerly used was
no longer available by the manufacturer and our previ-
ous (unpublished) results indicate that a longer clotting
time is needed to obtain reliable results (40 min vs.
20 min used by Orset et al [2]). One group (n = 12,
group 1) received 5 mg/kg t-PA and a second group
(n = 8, group 2) 10 mg/kg t-PA. 10% of t-PA was admi-
nistered as a bolus and 90% as a continuous infusion in
a total volume of 250 μL over a 40 min interval using a
syringe infusion pump (CMA, Stockholm, Sweden).Control animals (n = 8, group 3) were infused with 250
μL saline under the same conditions.
Three animals (group 4) received 10 mg/kg t-PA
90 min after MCAo inside the MRI for chronological se-
quence imaging of reperfusion. All animals were sacri-
ficed after 1 week.
Functional testing
Functional scores adapted from Chen et al [8] were
obtained one day after stroke induction and before
sacrifice.
MRI
The imaging experiments of groups 1–3 were performed
on a 9.4 T Biospec 94/20 USR (Bruker, Germany) small
animal system equipped with 740 mT/m gradients and a
1H surface cryo probe (Bruker, Germany) 24 h after
MCAo (and t-PA administration respectively). The ani-
mals were anesthetised with 1.5-2% isofluran and posi-
tioned into the magnet with a laser-controlled system
for the animal cradles. Respiratory frequency and body
temperature were monitored throughout the experiment
and the latter was maintained with a water heating pad.
The protocol consisted of a T2-weighted RARE sequence
[9], a diffusion weighted multi-shot EPI sequence to ob-
tain the apparent diffusion coefficient (ADC)-maps [10]
and a 3D flow-compensated gradient echo TOF angiog-
raphy [5,6]. Sequence parameters were set as follows.
RARE: TR=2.5 s; effective TE=60 ms; echo train length=
4; 4 averages; matrix size= 384×384; FOV=17×17 mm2 ;
slice thickness = 0.4 mm; measurement time (12
slices) = 6 min 40 s. EPI-Diffusion: 4 phase encoding steps,
TR=3 s; TE=20 ms; 4 averages; matrix size = 128×128;
slice thickness = 0.4 mm; 3 orthogonal diffusion directions
with three b-values b=0, 100 s/mm2 , 1000 s/mm2 ; meas-
urement time (12 slices) = 5 min 36 s. 3D-TOF:
TR=22 ms; TE=3.9 ms; Flip angle= 40°; matrix size:
256×256×128; FOV=16×16×16 mm3; measurement
time= 15 min 46 s. Angiograms were obtained by generat-
ing maximum intensity projections (MIPs) using ImageJ
software (National Institutes of Health, Bethesda, MD).
With the experimental setup and the described protocol it
is possible to acquire T2- weighted images, ADC maps
and TOF-MIPs within a measurement time of 28 min.
Histology
Seven days after MCAo – in contrast to 24 h in the
model by Orset et al [2] - the animals were re-
anesthetised as described above and perfused with 50 mL
of 4% formaldehyde in PBS. Their brains were removed,
formalin-fixed and paraffin-embedded. Serial coronal
sections (3 μm) were cut using a RM2265 microtome
(Leica, Bensheim, Germany) and mounted on silane-
Figure 1 Experimental timeline of MCA occlusion and reperfusion.
Figure 2 T2-weighted RARE images using the cryo-probe of consecutive slices acquired 24 h after MCAo clearly demonstrate the
infarcted region (a). ADC maps calculated of the diffusion-weighted images showing a significant decrease of the ADC in the ischaemic region
(b). Slice positioning is identical to Figure 2a. T2-weighted RARE image of the same mouse using a 1H linear birdcage resonator (72 mm i.d.)
instead of the cryo-probe (c).
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Figure 3 Turbo RARE images of consecutive slices acquired after MCAo and subsequent administration of t-PA possess only small
residual infarcted regions (a). ADC maps show a signal decrease in the identical area (b). On the haematoxylin-eosin stained slice the infarcted
region is consistent with the MR images (c).
Figure 4 Volume of the ischemic lesion of controls (white bar)
and t-PA treated mice with 10 mg/kg (black bar) and 5 mg/kg
(grey bar) quantified by MRI 9.4 T - T2 images. ***, p < 0.0001,
**, p < 0.001 and *, p < 0.05, one-way ANOVA, Bonferroni
post-hoc test.
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with haematoxylin-eosin to visualise the infarctions.
Assessment of infarct volumes and statistical analysis
Planimetric measurements of MRI images (ImageJ soft-
ware, National Institutes of Health, Bethesda, Md) were
performed and used to calculate lesion volumes, which
were corrected for brain oedema as described [11].
Data are expressed as mean ± standard deviation and
were analysed statistically using the PrismGraph 4.0 soft-
ware package (GraphPad Software). Data were analysed
by Bonferroni-corrected one-way ANOVA. P-values less
than 0.05 were considered to be statistically significant.
Results
Infarct volume
Figure 1 illustrates the experimental protocol with
thrombin injection, t-PA administration and MRI after
24 h. The infarcted region appears hyperintense in the
T2-weighted images (Figure 2a). Because of absence of
ischemic lesion on MRI we excluded five animals in the
10 mg group, two in the 5 mg group and two in the sa-
line group before further analysis. Saline treated animals
showed ischemic lesions that were restricted to the cor-
tex with a mean infarct volume of 19.8 ± 2.7 mm3
(n = 8). The ADC maps (Figure 2b) calculated of the
diffusion-weighted images revealed a significant signal
decrease in the region corresponding to the T2 hyperin-
tense area.
Reduction of infarct volume by t-PA infusion
Twenty animals were intravenously injected with t-PA
40 min after clot formation. Figure 3 shows one example
of the MRI measurements, 24 h after MCAo and therapy
with 10 mg/kg t-PA and its corresponding HE stained
coronary brain slice. Treatment with t-PA led to a sig-
nificant reduction of the infarct volume. The damaged
area calculated from the T2-weighted images is
0.7 ± 1.3 mm3 (n = 8). This represents a reduction of the
infarct size by approximately 96% (Figure 4). In the
haematoxylin-eosin stained brain sections as well, only a
small residual infarcted region is apparent (Figure 3c).By using 5 mg/kg of t-PA we found an infarct volume
between the group of 10 mg/kg and saline, with
10.9 ± 8.8 mm3 (n = 12).
Time course of reperfusion
Three animals (group 4) were reperfused with t-PA after
clot formation inside the MRI for chronological se-
quence imaging of reperfusion. Figure 5a demonstrates
serial maximum intensity projections (MIP) of the 3D-
TOF measurement along the coronal (upper row) and
axial (lower row) direction taken during reperfusion.
Prior to t-PA bolus injection there was no visible cere-
bral blood flow in the right MCA posterior to the occlu-
sion (arrow). Already in the first scan ten minutes after
bolus injection, blood flow on the right MCA was appar-
ent. However, signal intensity was lower than on the
contralateral MCA. This reduction in cerebral blood
flow was attenuated during the first 60 min after reper-
fusion. 24 h after MCAo and reperfusion, no difference
Figure 5 High resolution MR angiography of a mouse during reperfusion. Before t-PA treatment, there is no cerebral blood flow in the
right MCA. Ten minutes after starting t-PA infusion, flow on the MCA is re-established. However, signal intensity is lower than in the contralateral
MCA. This reduction in cerebral blood flow is attenuated during the first 60 min after reperfusion. 24 h after MCAo and reperfusion no difference
in signal intensity of the contralateral and ipsilateral MCAs is obvious (a). ADC Maps during reperfusion (b). In the first 75 min after reperfusion a
slight decrease in the signal intensity of ADC is visible and 24 h after reperfusion the infarcted area is larger than at the onset. This is also
detectable in the T2-weighted measurement (c).
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eral MCAs was visible.
In the ADC maps there was a minor reduction in the
volume of ADC after t-PA bolus injection (Figure 5b). In
the following 22 h after reperfusion the ADC hypoin-
tense area increased. No hyperintense signal in the T2-
weighted images could be seen in the first two hours
after stroke induction (data not shown). 24 h after clot
formation the infarcted area in the T2-weighted images
(Figure 5c) was consistent with the area seen in the
ADC maps.
Functional testing
Neurological deficits were measured one day after
MCAo using the modified Neurological Severity Score
(mNSS) [8] which is a composite of motor, sensory,reflex and balance tests. We could not observe any
neurological deficits neither in mice in the saline treated
nor in the t-PA treated group one day after surgery or
before sacrifice by using this score system.
Discussion
In this study we demonstrate that MRI at high magnetic
field strength with 9.4 T in combination with the use of
a cryo probe facilitates efficient stroke imaging even in
the mouse brain with very small anatomical sizes. These
measurements allow an accurate determination of the
infarcted area and even reperfusion in vivo and validate
the variation of the infarcted area in a time-dependent
manner in a mouse model of thromboembolic stroke.
We used the protocol for stroke induction referring to
the work from Orset et al [2]. The advantage of this
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is the high reproducibility. The clot is always located at
the same place and so far no secondary microthrombi in
small arteries or capillaries could be observed [2]. There-
fore this model leads to clot formation with accurate
and reproducible brain damage.
As many knockout mice are bred in a C57BL/6 back-
ground we adapted the protocol established in swiss
mice for the C57BL/6 mouse strain. It is known that the
susceptibility to cerebral ischemia can vary in different
mouse strains [14]. One indication for the varying sus-
ceptibility is that we observed greater infarct volumes in
non-t-PA treated animals compared to Orset et al. [2]
and had to use a higher amount of thrombin (1.5U com-
pared to 0.75U) to get reliable infarcts. In contrast the
infarct volume in t-PA treated animals was smaller than
in the work by Orset et al. [2] despite later injection -
after 40 min post-stroke and not after 20 min. The effi-
cacy of t-PA treatment with 10 mg/kg body weight was
quite high, reducing the infarct volume below 10 mm3.
We therefore suggest using the lower tPA concentration
(5 mg/KG) for evaluating combination therapies with
tPA in further studies if using this animal strain and this
model. By using 5 mg/kg body weight of t-PA we found
a favourable dose dependency concerning the infarct
volume compared to 10 mg/kg t-PA and saline
treatment.
However, for adjunct therapies of t-PA this model is
superior to others because of its local thrombus forma-
tion, the dose-dependent therapeutical effect of t-PA and
the opportunity of giving additional medical treatment.
The non-invasive proof of infarction, reperfusion and
temporal evolution could be easily evaluated by our pre-
sented MRI technique using a cryo probe. The advan-
tage of using this high-field MR technique could be
demonstrated in Figure 5b where a hyperintense region
beside the hypointense lesion could be seen in ADC
images before thrombolysis. This hyperintensity diseap-
pers in the early recanalisation period (50 and 75 min
post t-Pa) but reappear 24 h later as a second ischemic
lesion, probably representing a reperfusion injury. Beck-
mann and colleagues [7] used a 3D gradient-echo se-
quence to visualize the cerebral vasculature in the
mouse brain in a model of cerebral ischemia. They used
a mouse model of focal cerebral ischemia where a thread
is inserted into the internal carotid artery to occlude the
origin of the MCA. The mouse model we used with local
injection of purified thrombin directly into the right
MCA followed with t-PA induced reperfusion, simulates
the clinical situation more realistically than the filament
model. Furthermore the 3D-TOF measurements used in
this study can visualize single blood vessels with a small
diameter of approximately 100 μm and deliver a proper
and direct assessment of the success of occlusion of themurine MCA and enables the visualization of reperfu-
sion at different time points even in distal MCA
branches. Furthermore, it is possible to depict the devel-
opment of t-PA induced reperfusion as a function of
time. To proof the occlusion and reperfusion by MRI
measurements provides more reliable data than measur-
ing the local cerebral blood flow by laserdoppler flowme-
try as used in the work of Orset et al [2], because the
MRI measurement is not as susceptible to extern influ-
ences as the laserdoppler probe. Another method for
evaluation of cerebral blood flow is continuous arterial
spin labeling (CASL), which will be even better if a cryo
coil – like in our experiments - is used [7].
Another important advantage of this animal model is
the low mortality rate of the infarcted mice. In other
stroke models the number of animals that die during the
surgical procedure or in the time until evaluation of
brain damage is quite high [15,16]. No of the 28 animals
used in this study died during surgery or in the first
seven days. This makes evaluation of long term outcome
like inflammatory processes, neuroplasticity or neurore-
generation possible.
In summary, the use of a cryo probe has improved the
imaging quality tremendously. The opportunity to view
recanalisation by MR-angiography allows therapeutical
interventions in a model of clot and clot-lysis and there-
fore extends the list of possible treatments and applica-
tions in this stroke animal model and C57BL76 mice.
Competing interests
The authors declare that they have no competing interests.
Authors´ contributions
MF directed the study, designed experiments, analyzed data and drafted the
manuscript; FL, designed and performed experiments, analyzed data and
drafted the manuscript; PH, SG, AL and AA designed and performed
experiments, analyzed data and contributed to manuscript writing; LRS
provided specific input to MRI experiments including experimental design
and data analysis; MGH, SM funded the study, and designed experiments. All
authors read and approved the final manuscript.
Acknowledgments
The support of Marén Neumann and Felix Hörner is gratefully
acknowledged. This research has been supported by the European Union's
Seventh Framework Programme (FP7/2007-2013) under grant agreements n
201024 and n 202213 (European Stroke Network).
Author details
1Department of Neurology, Universitätsmedizin Mannheim, University of
Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. 2Computer
Assisted Clinical Medicine, Universitätsmedizin Mannheim, University of
Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
3Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11,
97080, Würzburg, Germany.
Received: 14 August 2012 Accepted: 6 September 2012
Published: 12 September 2012
References
1. Mergenthaler P, Dirnagel U, Meisel A: Pathophysiology of stroke: lessons
from animal models. Metab Brain Dis 2004, 19:151–167.
Langhauser et al. Experimental & Translational Stroke Medicine 2012, 4:18 Page 7 of 7
http://www.etsmjournal.com/content/4/1/182. Orset C, Macrez R, Young A, Panthou D, Angles-Cano E, Maubert E, Agin V,
Vivien D: Mouse model of in situ thromboembolic stroke and
reperfusion. Stroke 2007, 38:2771–2778.
3. Ratering D, Baltes C, Nordmeyer-Massner J, Marek D, Rudin M: Performance
of a 200-MHz cryogenic RF Probe designed for MRI and MRS of the
murine brain. Magn Reson Med 2008, 59:1440–1447.
4. Baltes C, Radzwill N, Bosshard S, Marek D, Rudin M: Micro MRI of the
mouse brain using a novel 400 MHz cryogenic quadrature RF probe.
NMR Biomed 2009, 22:834–842.
5. Masaryk TJ, Modic MT, Ross JS, Ruggieri PM, Laub GA, Lenz GW, Haacke EM,
Selman WR, Wiznitzer M, Harik SI: Intracranial circulation: preliminary
clinical results with three-dimensional (volume) MR angiography.
Radiology 1989, 171:793–799.
6. Lin W, Tkach JA, Haacke EM, Masaryk TJ: Intracranial MR angiography:
application of magnetization transfer contrast and fat saturation to short
gradient-echo, velocity compensated sequences. Radiology 1993,
186:753–761.
7. Beckmann N, Stirnimann R, Bochelen D: High-resolution magnetic
resonance angiography of the mouse brain: application to murine focal
cerebral ischemia models. J Magn Reson 1999, 140:442–450.
8. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp
M: Intravenous administration of human umibical cord blood reduces
behavioural deficits after stroke in rats. Stroke 2001, 32:2682–2688.
9. Hennig J, Nauerth A, Friedburg H: RARE imaging: a fast imaging method
for clinical MR. Magn Reson Med 1986, 3:823–833.
10. Le Bihan D: Diffusion and perfusion magnetic resonance imaging: Applications
to functional MRI. New York: Raven; 1995.
11. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR: A
semiautomated method for measuring brain infarct volume. J Cereb
Blood Flow Metab 1990, 10:290–293.
12. Kudo M, Aoyama A, Chamorro S, Fukunaga N: An animal model of
cerebral infarction. Homologous blood clot emboli in rats. Stroke 1982,
13:505–508.
13. Atochin DN, Murciano JC, Gürsoy-Ozdemir Y, Krasik T, Noda F, Ayata C,
Dunn AK, Moskowitz MA, Huang PL, Muzykantov VR: Mouse model of
microembolic stroke and reperfusion. Stroke 2004, 35:2177–2182.
14. Yang G, Kitagawa K, Matsushita K, Mabuchi T, Yagita Y, Yanagihara T,
Matsumoto M: C57BL/6 strain is most susceptible to cerebral ischemia
following bilateral common carotid occlusion among seven mouse
strains: selective neuronal death in the murin transient forebrain
ischemia. Brain Res 1997, 752:209–218.
15. Austinat M, Braeuninger S, Pesquero JB, Brede M, Bader M, Stoll G, Renné T,
Kleinschnitz C: Blockade of bradykinin receptor B1 but not bradykinin
receptor B2 provides protection from cerebral infarction and brain
edema. Stroke 2009, 40:285–293.
16. Romanos E, Planas AM, Amaro S, Chamorro A: Uric acid reduces brain
damage and improves the benefits of rt-PA in a rat model of
thromboembolic stroke. J Cereb Blood Flow Metab 2007, 27:14–20.
doi:10.1186/2040-7378-4-18
Cite this article as: Langhauser et al.: Thromboembolic stroke in C57BL/6
mice monitored by 9.4 T MRI using a 1H cryo probe. Experimental &
Translational Stroke Medicine 2012 4:18.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
